Save
Email
Print
Share
RSSBrowse News Stories
11 to 20 of 395 stories
view headlines only
-
Screening Detects Ovarian Cancer Using Neighboring Cells
April 22, 2013 — Pioneering biophotonics technology detects the early presence of ovarian cancer in humans by examining cells easily brushed from the neighboring cervix or uterus, not the ovaries themselves. The ... > full story -
Discovery Brings Hope of New Tailor-Made Anti-Cancer Agents
April 21, 2013 — Scientists have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients. The development of the compound, called WEHI-539, is ... > full story -
Soy-Based Compound May Reduce Tumor Cell Proliferation in Colorectal Cancer
April 11, 2013 — Scientists have developed a soy-based treatment for colorectal cancer, a promising agent in ovarian cancer, and a new drug target for advanced prostate ... > full story -
Engineered T Cells Kill Tumors but Spare Normal Tissue in an Animal Model
April 7, 2013 — Researchers devised a next gen cancer immune approach in which the activation signal for T cells is physically dissociated from a second costimulatory signal for immune cells. The two CARs carry ... > full story -
Two-Step Ovarian Cancer Immunotherapy Made from Patients' Own Tumor Benefits Three Quarters of Trial Patients
April 7, 2013 — As many as three quarters of advanced ovarian cancer patients appeared to respond to a new two-step immunotherapy approach -- including one patient who achieved complete remission -- according to new ... > full story -
Targeted Toxin Active in Platinum-Resistant Ovarian Cancers
April 7, 2013 — Researchers have found that a novel antibody-guided drug achieves responses in platinum drug-resistant ovarian ... > full story -
New Type of Experimental Drug Active in Platinum-Resistant Ovarian Cancers
April 7, 2013 — The antibody-drug conjugate DMUC5754A, a novel member of a relatively new class of drugs, showed activity in women with ovarian cancer, even those with hard-to-treat, platinum-resistant disease, in a ... > full story -
Cisplatin-Resistant Cancer Cells Sensitive to Experimental Anticancer Drugs Called PARP Inhibitors
April 3, 2013 — Poly (ADP-ribose) polymerase inhibitors may be a novel treatment strategy for patients with cancer that has become resistant to the commonly used chemotherapy drug cisplatin, according to data from a ... > full story -
Functional Ovarian Tissue Engineered in Lab
March 26, 2013 — A proof-of-concept study suggests the possibility of engineering artificial ovaries in the lab to provide a more natural option for hormone replacement therapy for ... > full story -
New DNA Sequences Home in on Breast, Ovarian Cancer Risk
March 20, 2013 — Researchers have identified new DNA sequences associated with breast cancer -- the most common cancer among women, with an average risk of developing the disease of 10 percent -- and ovarian cancer, ... > full story
Search ScienceDaily
Number of stories in archives: 140,690
more 
